Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products

This publication has 11 references indexed in Scilit:

• Dry powder inhalers (DPIs)—A review of device reliability and innovation
  International Journal of Pharmaceutics, 2008
• In Vitro / In Vivo Comparisons in Pulmonary Drug Delivery
  Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
• Studies of the Human Oropharyngeal Airspaces Using Magnetic Resonance Imaging IV—The Oropharyngeal Retention Effect for Four Inhalation Delivery Systems
  Journal of Aerosol Medicine, 2007
• The DiskusTM: a review of its position among dry powder inhaler devices
  International Journal Of Clinical Practice, 2007
• Particle deposition measurements and numerical simulation in a highly idealized mouth–throat
  Journal of Aerosol Science, 2004
• Bioavailability of Orally Administered Micronised Fluticasone Propionate
  Clinical Pharmacokinetics, 2000
• Particle Deposition in a Cast of Human Oral Airways
  Aerosol Science and Technology, 1999
• Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography–tandem mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1998
• Impact of Oropharyngeal Deposition on Inhaled Dose
  Journal of Aerosol Medicine, 1998
• Trials to assess equivalence: the importance of rigorous methods: Fig 1
  BMJ, 1996